The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects.

Breuer, M. E.; Chan, J. S.; Oosting, R. S.; Groenink, L.; Korte, S. M.; Campbell, U.; Schreiber, R.; Hanania, T.; Snoeren, E. M.; Waldinger, M.; Olivier, B.

Eur Neuropsychopharmacol 2008, 18, 908-16.